期刊文献+

膀胱癌组织中乳腺癌扩增基因1的表达及其意义

Expression of AIB1 in bladder cancer and its significance
原文传递
导出
摘要 目的 探讨膀胱癌组织中乳腺癌扩增基因1(AIB1)基因的表达及其临床意义.方法 收集30例因膀胱癌行全膀胱切除术或经尿道膀胱癌电切术的标本,术前病理检查均为尿路上皮癌,采用免疫组织化学方法检测膀胱癌组织和癌旁组织中AIB1的表达情况.结果 膀胱癌组织AIB1的阳性表达率高于癌旁组织[43.3%(13/30)比3.3%(1/30),x2=4.316,p<0.05],高分期膀胱癌组织AIB1的阳性表达率高于低分期膀胱癌组织[T1、T2、L期分别为25.0%(2/8)、42.9%(6/14)、62.5%(5/8),x2=4.623,P<0.05].AIB1的表达与患者性别、年龄、肿瘤数目和病理分级无明显相关性(均P>0.05).结论 AIB1与膀胱癌关系密切,有可能成为判断膀胱癌预后的重要指标. Objective To investigate the expression of AIB1 protein in bladder cancer and its significance.Methods 30 cases of bladder cancer and 30 adjacent normal tissues were collected from 30 patients underwent radical or TURBt.The level of AIB1 protein expressed in these tissues were detected by immunohitochemical method.Results The positive rate of AIB1 protein in bladder carcinoma was higher than that in the normal tissues [43.3 % (13/30) vs 3.3 % (1/30),x2 =4.316,P < 0.05].The positive rate of AIB1 in T3 stage was higher than that in T1 or T2 stage [62.5 % (5/8) vs 25.0 % (2/8),42.9 % (6/14),x2 =4.623,P < 0.05].No correlation was found between the expression of AIB1 protein and the sex,age,multiplicity or pathological grade (P > 0.05).Conclusions There is a close relationship between AIB1 and bladder cancer.AIB1 might have great value on the prognosis of patients with bladder cancer.
出处 《肿瘤研究与临床》 CAS 2013年第12期826-827,共2页 Cancer Research and Clinic
关键词 膀胱肿瘤 乳腺癌扩增基因1 免疫组织化学 Urinary bladder neoplasms AIB1 Immunohitochemistry
  • 相关文献

参考文献1

二级参考文献13

  • 1Anzick SI., Kononen RL, Walker RL, et al. AIB1, a steroid receptor coactivator amplification in breast and ovarian cancer [J]. Science,1997,277(5328):965-968.
  • 2Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and overexpression of the AIB1 nuclear receptor co-activator genein primary gastric cancers[J]. Int J Cancer, 2000,89 (3) :217-223.
  • 3Xu Y, Chen Q, Li W, et al. Overexpression of transcription al coactivator AIB1 promotes hepatocellular carcinoma pro gression by enhancing cell proliferation and invasiveness[J]. Oncogene,2010,29(23) :3386-3397.
  • 4Henke RT, Haddad BR, Kim SE,et al. Overexpression ofthe nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma[J]. Clin Cancer Res, 2004,10(18 Pt 1) :6134-6142.
  • 5He LR, Zhao HY, Li BK, et al. Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients[J]. Ann Oncol,2010,21(8) :1675-1681.
  • 6Carnero A, Blanco-Aparicio C, Renner O, et al. The PTEN/ PI3K/AKT signalling pathway in cancer, therapeutic impli cations[J]. Curt Cancer Drug Targets,2008,8(3) :187-198.
  • 7Garcia-Echeverria C, Sellers WR. Drug discovery approaches targeting the PI3K/Akt pathway in cancer[J]. Oncogene, 2008,27(41) :5511-5526.
  • 8Torres Arzayus MI, Font de Mora J, Yuan J, et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene[J]. Cancer Cell, 2004,6(3):263-274.
  • 9Luo JH, Xie D, Liu MZ, et al. Protein expression and am plification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prog nostic marker of patient survival[J]. Int J Cancer,2008,122(Ii):2554-2561.
  • 10Oh A, List HJ, Reiter R, et al. The nuclear receptor coacti vator AIB1 mediates insulin like growth factor I-induced phe notypic changes in human breast cancer cells [J]. Cancer Res,2004,64(22) :8299-8308.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部